OR WAIT null SECS
August 18, 2021
Cipla receives final approval from FDA for its abbreviated new drug application for difluprednate ophthalmic emulsion 0.05%.
TriRx hosts various leaders at a ribbon-cutting ceremony for their new facility.
BlueAllele has been granted a US patent for its advanced gene-editing technology, PALIDON, which is compatible with existing gene editing nucleases and delivery systems.
The Cleveland, Ohio facility will produce critical anti-infective drug products for US hospitals.
Artiva Biotherapeutics’s new R&D and GMP manufacturing center in San Diego, Calif., for NK cell therapies is expected to open in 2022.
August 17, 2021
Thermo Fisher’s manufacturing site in Greenville, NC was recognized for manufacturing excellence.
Syngene’s additions include a new microbial facility and an expanded mammalian facility.
Primates inoculated with CV2CoV show improved immune response and protection from various COVID variants.
FDA has granted its first approval for an idiopathic hypersomnia treatment.
Biotage’s new facility in Cardiff, UK, will produce lipids using large-scale flash purification.